23/05/2025
Cure MAPT FTD is a global patient advocacy organization focused on finding a cure for frontotemporal dementia (FTD) caused by a mutations in the MAPT gene.
With members in Canada, England, France, New Zealand, Australia, South America, Isreal and the U.S., Cure MAPT FTD unites families, researchers, and advocates worldwide to push for a disease modifying solution.
Cure MAPT FTD is currently seeking MAPT-mutation carriers around the world in an effort to count, record, and galvanize these positive carriers so that we can advocate for trials that would result in a cure. By demonstrating this disease is severely undercounted, Cure MAPT FTD hopes to convince researchers, pharmaceutical executives, and governmental bodies to fast track these potentially life-saving trials.
For more information go to www.curemaptftd.org. And please join their efforts by reaching out to at hello@curemaptftd.org.
Cure MAPT FTD raises awareness of the MAPT genetic mutation causing FTD, assists a global network of MAPT families, and advocates for trials that will lead to a cure.